Cost-minimization analysis of application acetylsalicylic acid in cardiac elderly patients

Abstract

Objective: To conduct a comparative pharmacoeconomic analysis of Cardiomagnyl and Trombo ACC during antiplatelet therapy of cardiac patients. Methodology: Clinical studies have demonstrated equal efficacy of drugs containing acetylsalicylic acid so this analysis model is a «cost-minimization» and consists of a single line therapy, providing short-term economic evaluation (12 months therapy). Results: Antiplatelet therapy with Cardiomagnyl in cardiac elderly patients reduce the cost of the annual rate of pharmacotherapy for 220 rubles in the calculation of per patient compared with therapy Trombo ACC by reducing the cost of correction the side effects. Expenses for correction of side effects when using Cardiomagnyl less on 737 rubles per patient than with Thrombo ACC.

Keywords

• фармакоэкономика
• анализ минимизации затрат
• ишемическая болезнь сердца
• антиагреганты
• ацетилсалициловая кислота
• нпвп-ассоциированная гастропатия
• pharmacoeconomics
• cost-minimization analysis
• coronary heart disease
• antiplatelet agents
• acetylsalicylic acid
• nsaid-associated gastropathy